Robert McNamara - 05 Jun 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma
Issuer symbol
RCEL
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
06 Jun 2024, 19:14:42 UTC
Previous filing
17 Aug 2023
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +9,200 +56% 25,749 05 Jun 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +3,943 $0.000000 3,943 05 Jun 2024 Common Stock 3,943 $9.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2 Includes unvested RSUs.